Pfizer and BioNTech’s COMIRNATY Gets FDA Approval for Seniors and High-Risk Individuals Ages 5-64 Read more
Lilly’s Oral GLP-1, Orforglipron, Succeeds in Third Phase 3 Trial, Paving Way for Global Obesity Filings Read more
Johnson & Johnson Invests $2B in New State-of-the-Art Manufacturing Facility in North Carolina Read more
Andelyn Biosciences and Amplo Biotech Partner to Advance Gene Therapies for Neuromuscular Junction Disorders Read more